Global Cloud Computing IaaS in Life Science Market Size To Exceed USD 97.99 Billion by 2033: Market Growth Report

RELEASE DATE: Jun 2025 Author: Spherical Insights
The Global Cloud Computing IaaS in Life Science Market Size is Expected to Grow from USD 6.05 Billion in 2023 to USD 97.99 Billion by 2033, at a CAGR of 32.11% during the forecast period 2023-2033

Table of Contents

Historical Data, Premium Insights, Market Dynamic, Analysis and Projection, By Product, Analysis and Projection, By Application, Analysis and Projection, By End-Use, Analysis and Projection, By Regional Analysis, Competitive Landscape, Company Profiles, Market Revenue, Sale and Price Analysis


Related Topics

Artificial Intelligence (AI) in Life Science Market Size Application Development Lifecycle Management (ADLM) Market Size System-in-Package Die Market Size MENA Wealth Management Market Size

Global Cloud Computing IaaS in Life Science Market Size To Exceed USD 97.99 Billion by 2033                

According to a research report published by Spherical Insights & Consulting, The Global Cloud Computing IaaS in Life Science Market Size is Expected to Grow from USD 6.05 Billion in 2023 to USD 97.99 Billion by 2033, at a CAGR of 32.11% during the forecast period 2023-2033.  

       

Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Cloud Computing IaaS in Life Science Market Size, Share, and COVID-19 Impact Analysis, By Component (Hardware, Software, and Services), By Application (Nonclinical Information Systems (NCIS) and Clinical Information Systems), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.

 

The global cloud computing infrastructure as a service (IaaS) in life science market refers to the sector that delivers virtualized computing resources, such as storage, servers, and networking, over the internet, specifically tailored for the life sciences industry. This market supports pharmaceutical, biotechnology, and healthcare research organizations by enabling scalable, flexible, and cost-effective IT infrastructure to manage vast datasets, streamline operations, and accelerate innovation in areas such as drug discovery, clinical trials, and personalized medicine. Furthermore, Key driving factors propelling the growth of the global Cloud Computing Infrastructure as a Service (IaaS) market in life sciences include the increasing prevalence of chronic diseases, which necessitates advanced data management solutions; the surge in multinational and multistate clinical trials requiring scalable and secure data storage; and the expansion of gene therapy research demanding robust computational resources. Additionally, the need for efficient data sharing and collaboration across global research teams, coupled with the benefits of reduced IT infrastructure costs and enhanced scalability offered by cloud solutions, further accelerates market adoption. However, restraining factors for the global cloud computing IaaS in life science market include data security concerns, compliance with strict regulatory requirements, high migration costs, limited internal expertise, and potential service disruptions.

 

The software segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.              

On the basis of the component, the global cloud computing IaaS in life science market is divided into hardware, software, and services. Among these, the software segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth is attributed to the increasing digital transformation, demand for automation, and integration of AI and analytics. Its anticipated strong CAGR is driven by rising adoption across industries, scalability, and continuous innovation, positioning software as essential for operational efficiency and competitive advantage in the forecast period.

 

The clinical information systems segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period.             

On the basis of the application, the global cloud computing IaaS in life science market is divided into nonclinical information systems (NCIS) and clinical information systems. Among these, the clinical information systems segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period. The segmental growth is attributed to the rising demand for efficient patient data management, improved clinical workflows, and regulatory compliance. Its projected remarkable CAGR is driven by growing healthcare digitization, integration of EHRs, and increasing investments in advanced health IT infrastructure to enhance patient care and outcomes.

 

North America is projected to hold the largest share of the global cloud computing IaaS in life science market over the forecast period.

North America is projected to hold the largest share of the global cloud computing IaaS in life science market over the forecast period. The regional growth is attributed to its advanced healthcare infrastructure, high adoption of cloud technologies, and strong presence of key life sciences companies. Government support for digital health initiatives, along with significant investments in R&D and innovation, further boosts the region's market share throughout the forecast period.

 

Asia Pacific is expected to grow at the fastest CAGR in the global cloud computing IaaS in life science market during the forecast period. The regional growth is attributed to the rapid digital transformation, increasing healthcare investments, and growing demand for cloud-based solutions. Expanding healthcare infrastructure, rising adoption of electronic health records (EHRs), and government initiatives to enhance healthcare systems further drive this region's market growth.

 

Company Profiling

Major vendors in the global cloud computing IaaS in life science market are Cleardata Networks, Inc., Dell Inc., Global Net Access (GNAX), Carecloud Corporation, Vmware, Inc., Carestream Health, Inc., IBM Corporation, Iron Mountain, Inc., Athenahealth, Inc., Oracle Corporation, and others.

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global cloud computing IaaS in life science market based on the below-mentioned segments: 

 

Global Cloud Computing IaaS in Life Science Market, By Component

  • Hardware
  • Software
  • Services

 

Global Cloud Computing IaaS in Life Science Market, By Application

  • Nonclinical Information Systems (NCIS)
  • Clinical Information Systems

 

Global Cloud Computing IaaS in Life Science Market, By Regional

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Recent Insights


Your personal details are safe with us, Privacy Policy.

Thank You!

We have received your message and would like to thank you for writing to us. If your inquiry is urgent, please use the telephone number listed below to talk to one of our staff members. Otherwise, we will reply by email as soon as possible.

+1 303 800 4326 +91 9561448932 emailsales@sphericalinsights.com

We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies